OLBA HEALTHCARE (2689) Q4 2026 earnings summary

Executive summary

• Net sales increased by 3.2% year-over-year to ¥126,595 million for the fiscal year ended June 30, 2026.

• Operating profit declined by 15.2% year-over-year to ¥1,679 million, and profit attributable to owners of parent fell 22.2% to ¥1,112 million.

• Comprehensive income decreased by 7.4% year-over-year to ¥1,294 million.

Financial highlights

• Gross profit rose to ¥14,179 million from ¥13,909 million year-over-year.

• Operating margin declined to 1.3% from 1.6% year-over-year.

• Basic earnings per share dropped to ¥187.67 from ¥241.43 year-over-year.

• Cash and cash equivalents at period end decreased to ¥2,590 million from ¥3,420 million.

Outlook and guidance

• Dividend for the fiscal year ending June 30, 2027 remains undecided due to a planned business integration with DVx Inc. on September 1, 2026.

• No consolidated financial forecasts for FY2027 have been provided pending the integration.